Sports Supplement Labels Are Legally Allowed to Make Unverified Claims, Misleading Athletes
sportssports0 views
What: Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), sports nutrition supplements can make 'structure/function' claims (e.g., 'supports muscle growth,' 'enhances endurance') without providing any clinical evidence to the FDA before going to market. The FDA can only act after a product is sold and proven harmful — it cannot require pre-market approval. In December 2025, the FDA issued new guidance on DSHEA disclaimer requirements, acknowledging the system's inadequacy but still relying on post-market enforcement. Why it matters: Athletes and fitness enthusiasts spend billions annually on pre-workouts, BCAAs, testosterone boosters, and fat burners based on label claims that have never been independently verified. So what? Third-party testing (NSF Certified for Sport, Informed Sport) repeatedly finds that 15-25% of supplements contain ingredients not listed on the label, including banned substances that can cause positive drug tests for competitive athletes. So what? Without pre-market approval, contaminated or adulterated supplements reach consumers before anyone checks them — the FDA's enforcement is reactive, not preventive. So what? Athletes face career-ending consequences from inadvertent doping violations caused by contaminated supplements they believed were safe, with WADA and USADA holding athletes strictly liable regardless of intent. So what? The supplement industry's $60+ billion US market operates on a trust framework with no verification mechanism, meaning honest manufacturers who invest in quality testing compete on an uneven playing field against those who make the same claims without the expense. Structural root cause: DSHEA (1994) explicitly exempted dietary supplements from the FDA's drug approval process, creating a regulatory gap that Congress has not closed in 30+ years. The FDA lacks funding and authority for proactive enforcement. The FTC can pursue misleading advertising claims but has limited bandwidth. Third-party certification (NSF, Informed Sport) is voluntary, expensive, and covers only a fraction of products on the market.
Evidence
Congressional Research Service (2025): detailed analysis of FDA's limited authority over supplement labeling claims under DSHEA (https://www.congress.gov/crs-product/R48623). FDA issued December 2025 letter on DSHEA disclaimer enforcement discretion, acknowledging regulatory gaps (https://www.nutritionaloutlook.com/view/fda-issues-letter-to-industry-explaining-dhsea-disclaimer-use-for-labels). Armstrong Teasdale (2026): enforcement expected to accelerate with shorter timelines between inspections and action (https://www.armstrongteasdale.com/thought-leadership/food-beverage-and-consumer-products-issues-to-watch-for-2026/). FDA labeling rules for supplements (2025): disease treatment/cure claims prohibited but structure/function claims require no pre-market evidence (https://www.sttark.com/blog/fda-labeling-rules-for-dietary-supplement-packaging-2025).